References
- Driver LC . Ethical Considerations for Chronic Pain Care During a Pandemic. Pain Medicine 21(7), 1327–1330 (2020).
- Choe K , Zinn E , Lu K , Hoang D , Yang LH . Impact of COVID-19 pandemic on chronic pain and opioid use in marginalized populations: a scoping review. Frontiers in Public Health, 11 (2023). https://www.frontiersin.org/articles/10.3389/fpubh.2023.1046683
- Doheny K . Telemedicine for Pain Management: Where Does it Stand as We Head into 2023? Practical Pain Management. (2022). www.practicalpainmanagement.com/news/telemedicine-for-pain-management-where-does-it-stand-as-we-head-into-2023
- Pronovost A , Peng P , Kern R . Telemedicine in the management of chronic pain: a cost analysis study. Can. J. Anesth. J. Can. Anesth. 56(8), 590–596 (2009).
- National Enforcement Action Results in 78 Individuals Charged for $2.5B in Health Care Fraud . United States Department of Justice: Office of Public Affairs (2023). www.justice.gov/opa/pr/national-enforcement-action-results-78-individuals-charged-25b-health-care-fraud
- Pandemic Response Accountability Committee . Insights on Telehealth Use and Program Integrity Risks Across Selected Health Care Programs During the Pandemic (2022). https://oig.hhs.gov/oei/reports/OEI-02-22-00150.asp
- U.S. House, U.S. Senate, Committee on Oversite and Reform, Committee of Homeland Security and Governmental Affairs . Consolidated Appropriations Act (CCA) (2023). www.congress.gov/bill/117th-congress/house-bill/2617/text
- Ellimoottil C . Understanding The Case For Telehealth Payment Parity. Health Affairs doi: 10.1377/forefront.20210503.625394 (2021).
- Department of Justice, Drug Enforcement Administration . Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation. Federal Register 88(40), 12875–12890 (2023).
- U.S. Drug Enforcement Administration . DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public. Drug Enforcement Administration (2023). www.dea.gov/press-releases/2023/05/09/dea-samhsa-extend-covid-19-telemedicine-flexibilities-prescribing
- Prillaman M . Climate change is making hundreds of diseases much worse. Nature 12, doi:10.1038/d41586-022-02167-z (2022).
- Joudrey PJ , Kolak M , Lin Q , Paykin S , Anguiano V Jr , Wang EA . Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder. JAMA Network Open 5(4), e227028 (2022).
- Black R . Pain Care in a Natural Disaster. Practical Pain Management 17(10), (2017). www.practicalpainmanagement.com/resources/practice-management/pain-care-natural-disaster
- Alkaissi H , McFarlane SI , Alkaissi H , McFarlane SI . Artificial Hallucinations in ChatGPT: Implications in Scientific Writing. Cureus 15(2), doi:10.7759/cureus.35179 (2023).
- Davenport T , Kalakota R . The potential for artificial intelligence in healthcare. Future Health J. 6(2), 94–98 (2019).
- Mincu D , Roy S . Developing robust benchmarks for driving forward AI innovation in healthcare. Nat. Mach. Intell. 4(11), 916–921 (2022).
- Panch T , Mattie H , Atun R . Artificial intelligence and algorithmic bias: implications for health systems. J. Glob. Health. 9(2), doi:10.7189/jogh.09.020318 020318 (2019).
- Obermeyer Z , Powers B , Vogeli C , Mullainathan S . Dissecting racial bias in an algorithm used to manage the health of populations. Science 366(6464), 447–453 (2019).
- Prictor M . Clinical Software and Bad Decisions: The “Practice Fusion” Settlement and Its Implications. J. Bioeth. Inq. 19(2), 187–190 (2022).